An increase in DDAH2 mRNA expression is further observed in glioblastoma, brain lower grade glioma and liver cancer samples, whilst a decrease is observed in cervical cancer samples relative to normal tissue (Figure 2B). Here, DDAH2 is linked to central nervous system cancer.